上海剑桥科技股份有限公司 二○二五年九月三日 上海剑桥科技股份有限公 司 2025 年第二次临时股东会文件 目 录 关于调整 2025 年半年度现金分红预案并制定 2025 年半年度现金分红方案的议 关于修订发行境外上市股份后适用的《公司章程（草案）》及相关议事规则（草 上海剑桥科技股份有限公司 2025 年第二次临时股东会文件 上海剑桥科技股份有限公司 为维护广大投资者的合法权益，确保本次股东会能够依法行使职权，根据《公 司法》、中国证监会发布的《上市公司股东会规则》等法律、法规和《公司章程》 的规定，特制定本次股东会须知如下： 一、股东会设秘书处，具体负责股东会召开等有关事宜。 二、股东会在召开过程中，应当以维护全体股东的合法权益、确保股东会正 常秩序和议事效率为原则，认真履行法定职责。 三、根据中国证监会《上市公司股东会规则》和上海重组办、上海证管办《关 于维护本市上市公司股东大会会议秩序的通知》 （沪重组办〔2002〕001 号）有关 规定，为保护所有股东的权益，尤其是维护因故未能出席股东会股东的权益，本 次股东会不发放任何形式的礼品。 四、与会股东依法享有发言权、质询权、表决权等各项权利。股东应认真 ...

上海剑桥科技股份有限公司 2025 年第二次临时股东会文件 二○二五年九月三日 | 2025 | 年第二次临时股东会须知 2 | | --- | --- | | 2025 | 年第二次临时股东会议程 3 | | 关于调整 | 2025 年半年度现金分红预案并制定 2025 年半年度现金分红方案的议 | | 案 4 | | | 关于修订发行境外上市股份后适用的《公司章程（草案）》及相关议事规则（草 | | | 案）的议案 7 | | 上海剑桥科技股份有限公司 2025年第二次临时股东会文件 上海剑桥科技股份有限公司 2025 年第二次临时股东会须知 为维护广大投资者的合法权益，确保本次股东会能够依法行使职权，根据《公 司法》、中国证监会发布的《上市公司股东会规则》等法律、法规和《公司章程》 的规定，特制定本次股东会须知如下： 一、股东会设秘书处，具体负责股东会召开等有关事宜。 四、与会股东依法享有发言权、质询权、表决权等各项权利。股东应认真履 行法定义务，自觉遵守股东会纪律，不得侵犯其他股东的权益，以保证股东会的 正常秩序。 五、股东会设"股东代表发言及解答问题"议程。股东要求在股东会上发言 的，请于会前填写" ...

证券代码：603083 证券简称：剑桥科技 公告编号：临 2025-052 上海剑桥科技股份有限公司 股票交易异常波动公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上海剑桥科技股份有限公司（以下简称"公司"）A 股股票于 2025 年 8 月 22 日、8 月 25 日和 8 月 26 日连续三个交易日内日收盘价格涨幅偏离值累 计达到 20%。根据《上海证券交易所交易规则》的有关规定，属于股票交易异 常波动的情况。 经向本公司控股股东 Cambridge Industries Company Limited（以下简称 "CIG 开曼"）、实际控制人 Gerald G Wong 先生及其一致行动人赵海波先生书 面征询核实，截至目前，控股股东、实际控制人及其一致行动人不存在涉及公 司的应披露而未披露的重大信息，不存在可能对公司股价形成重大影响的敏感 事项。 公司敬请广大投资者关注本公告正文第三部分提示的相关风险，理性决 策，审慎投资。 一、股票交易异常波动的具体情况 公司 A 股股票（证券代码：6 ...

Core Viewpoint - Cambridge Technology (603083) clarifies its current status regarding CPO and LPO technologies, indicating that it does not produce chips containing CPO technology and that LPO's contribution to revenue is minimal [1] Group 1: CPO Technology - The company does not currently manufacture chips that utilize CPO technology [1] - Core components related to CPO, such as the optical engine and external light source (ELSFP), are still in the stages of collaborative research and design [1] - No business revenue has been generated from CPO-related activities as of now [1] Group 2: LPO Business - The LPO business has sent samples for testing to several major North American clients [1] - Cumulative orders and shipment amounts for LPO in the first half of 2025 are projected to account for only about 0.03% of the company's revenue during the same period [1] - The contribution of LPO to the company's current performance is extremely limited [1]

| 代码 | 简称 | 收盘价 | 换手率 | 涨停板封单（万 | 封单资金（万 | 行业 | | --- | --- | --- | --- | --- | --- | --- | | | | （元） | （%） | 股） | 元） | | | 605255 | 天普股份 | 35.45 | 0.04 | 3824.96 | 135594.83 | 汽车 | | 603083 | 剑桥科技 | 80.17 | 0.92 | 876.71 | 70285.82 | 通信 | | 002261 | 拓维信息 | 40.27 | 11.61 | 1734.89 | 69864.02 | 计算机 | | 002131 | 利欧股份 | 5.31 | 26.39 | 9424.33 | 50043.18 | 机械设备 | | 002600 | 领益智造 | 14.92 | 8.34 | 3315.75 | 49470.95 | 电子 | | 600410 | 华胜天成 | 25.58 | 36.61 | 1024.99 | 26219.20 | 计算机 | | 600118 | 中国卫星 | 36.63 | 9.91 ...

中报业绩密集披露期 博亚精工 1、板带成形加工精密装备供应商,中报净利润同比增长61.26%。2 公司历经多次实 战演练和国家级重大活动的检验,包括纪念抗日战争胜利70周年,建军90周年、建国 70周年国庆等。 乔锋智能 公司主营业务为数控机床研产销,中报净利润同比增长56.43% 剑桥科技 7天4板 公司已向微软供应高速光模块产品,800G光模块产品已实现小批量发货,1.6T光模块 产品在给客户送样测试,中报净利润同比增长51.12% 能科科技 公司主营智能制造业务,,中报净利润同比增长18.75%。公司已构建涵盖"Al+产品 智能化"、"AI+工业研制智能化"及"工业软件+Al助手"三大核心产品体系,开发 出包含图纸识别、工艺推荐、质量检测、业务预测等多款垂域模型、覆盖二十余个工业 场景的应用Agent以及多款工业软件智能助手产品并实现应用落地。 启明信息 一汽集团旗下,主营企业数字运营和智慧营销及智慧汽车,中报净利润同比增长 2568.5% 三辉电气 公司主要从事电能计量仪器仪表,近两年来公司储能业务快速发展,在手订单充足,中 报净利润同比增长41.64% 三十点娱 公司是国内排名第二的页游运营平台,中 ...

两融数据显示，该股最新（8月25日）两融余额为15.03亿元，其中，融资余额为14.98亿元，近10日增加 4.46亿元，环比增长42.45%。 公司发布的半年报数据显示，上半年公司共实现营业收入20.35亿元，同比增长15.48%，实现净利润 1.21亿元，同比增长51.12%，基本每股收益为0.4500元，加权平均净资产收益率5.10%。（数据宝） 剑桥科技股价创出历史新高，截至9:33，该股上涨10.00%，股价报80.17元，成交量76.59万股，成交金 额6140.44万元，换手率0.29%，该股最新A股总市值达214.87亿元，该股A股流通市值214.87亿元。 证券时报·数据宝统计显示，剑桥科技所属的通信行业，目前整体跌幅为0.33%，行业内，目前股价上涨 的有38只，涨幅居前的有天孚通信、剑桥科技、长飞光纤等，涨幅分别为12.09%、10.00%、8.40%。股 价下跌的有90只，跌幅居前的有东土科技、*ST高鸿、利尔达等，跌幅分别为4.76%、4.76%、4.03%。 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） ...

Group 1: Stock Performance - Huawei's supply chain stocks surged on August 26, with companies like Helitai, Cambridge Technology, and Kaipu Cloud experiencing significant gains, including Helitai's three consecutive trading limits and Cambridge Technology's two consecutive trading limits [1] - Helitai reported a price of 3.72 with a rise of 10.06%, while Cambridge Technology reached 80.17 with a 10.00% increase [1] - Kaipu Cloud's stock price increased by 20.00% to 94.75, reflecting its partnership with Huawei [1] Group 2: Company Announcements - Huawei's supply chain company Huafeng Technology announced a record net profit of 151 million yuan for the first half of the year [1] - Huawei is set to launch a new AI SSD product on August 27, aimed at addressing challenges in AI training and inference [2] - The Huawei Connect 2025 event will take place from September 18-20, 2025, focusing on the theme of "Elevating Industry Intelligence" [2] Group 3: Technological Developments - The new AI SSD from Huawei is designed to overcome the "memory wall" issue in AI training, offering large capacity and improved data throughput efficiency [3] - AI SSDs are specifically optimized for AI workloads, featuring deep customizations in performance architecture and firmware algorithms [3] - Huawei's advancements in computing, storage, and communication may enhance the efficiency of computing resource allocation, potentially accelerating the penetration of domestic computing solutions [3]

Group 1: Company Insights - Teabo Bio is focusing on functional cure for hepatitis B, aiming for a combination of different mechanism drugs with interferons and nucleos(t)ide analogs for optimized treatment [1] - Teabo Bio is collaborating with Ligos to explore reinfection control after clearing infected cells and has acquired Jiutian Bio to leverage its gene therapy platform for more precise solutions [1] - Bai Li Tianheng is developing iza-bren in collaboration with BMS, with three new II/III phase overseas key registration clinical trials initiated for triple-negative breast cancer, EGFR mutation non-small cell lung cancer, and urothelial carcinoma [2] - Bai Li Tianheng has submitted the first nuclear medicine candidate drug BL-RC001 for domestic IND application and has nine DC drugs in clinical trials [2] - Cambridge Technology is focusing on broadband access and wireless networks in North America, with plans to increase production capacity for 800G series products to an annualized 2 million units [3] - Cambridge Technology's expansion plans are progressing smoothly, with potential financing from Hong Kong issuance next year to support increased production capacity [3] Group 2: Industry Trends - The trend in hepatitis B treatment is shifting towards a combination of therapies, indicating a growing recognition of the need for comprehensive disease management [1] - The oncology sector is seeing increased investment in clinical trials, with companies like Bai Li Tianheng aiming to become leaders in cancer treatment within five years [2] - The telecommunications industry is experiencing growth in demand for high-capacity products, as evidenced by Cambridge Technology's expansion plans and partnerships with major North American clients [3]

Group 1 - Cambridge Technology's main business focuses on broadband access and wireless networks, with unclear business plans for 2027 [1] - The company is progressing with multiple North American clients, with some product verifications nearing completion while others are still ongoing [1] - The production capacity of the 800G series products at Shanghai and Jiashan factories is being increased to an annualized 2 million units, with plans for further expansion in the first half of next year [1] Group 2 - Shanghai Jinglin Asset Management Company is a private fund management company registered with the Asset Management Association of China, focusing on investments in domestic and foreign listed company stocks [2] - The company has a strong track record, with the Jinglin Stable Trust achieving a compound annual return of 26.84% as of April 30, 2015, compared to the 14.85% return of the CSI 300 Index during the same period [2] - Jinglin Asset Management has a professional team of over 50 members, many of whom have extensive experience in their respective fields and have worked in renowned financial or regulatory institutions [2]